// App-Quantinova.ai

2382 : Clinical Outcome After Occurrence Of Vitamin K-Antagonist Related Major Bleeding Complication: A Two-Year Observational Follow-Up Study

Researchers

Presenter

  • Nakisa Khorsand

Principal Investigators

  • Reinier M van Hest

  • Shakiba Zahedin Labbaf

  • Paula Ypma

  • Helga W Vermaas

  • Nic J.G.M. Veeger

  • Karina Meijer

Medical Centers

  • Thrombosis Services The Hague, The Hague, Netherlands

  • Division of Hemostasis and Thrombosis, Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands

  • Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands

  • Department of Pathology, University of Groningen, University Medical Center Groningen,, Groningen, Netherlands

  • The Hague Central Hospital Pharmacy, Clinical Pharmacy, The Hague, Netherlands

  • Hematology, HagaZiekenhuis, The Hague, Netherlands

  • Department of Clinical Epidemiologic Biostatics, Academic Medical Center, Amsterdam, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • Prothrombin

Drug/Treatment

  • Prothrombin complex

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim